Cas:61203-94-9 (trans-4-Propylcyclohexyl)benzene manufacturer & supplier

Chemical Name:(trans-4-Propylcyclohexyl)benzene

CAS.NO:61203-94-9

Synonyms:trans-(4-Propylcyclohexyl)benzene;trans-(4-amino-cyclohexyl)-acetic acid ethyl ester hydrochloride;trans-1-phenyl-4-propylcyclohexane;ethyl (trans-4-aminocyclohexyl)acetate hydrochloride;trans-4-Methyl-cyclohexyl-essigsaeure;Ethyl 2-(trans-4-aminocyclohexyl)acetate hydrochloride;(trans-4-methyl-cyclohexyl)-acetic acid;(trans-4-n-propylcyclohexyl)benzene;trans-(4-amino-cyclohexyl)-acetic acid;trans-4-propyl-1-phenylcyclohexane;Ethyl trans-2-(4-aminocyclohexyl)acetate hydrochloride;(trans-4-Amino-cyclohexyl)-essigsaeure

Molecular Formula:C₁₅H₂₂

Molecular Weight:202.33500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:289.9ºC at 760 mmHg

Density:0.9g/cm3

Index of Refraction:1.499

PSA:

Exact Mass:202.17200

LogP:4.76050

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like trans-(4-Propylcyclohexyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(trans-4-Amino-cyclohexyl)-essigsaeure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 2-(trans-4-aminocyclohexyl)acetate hydrochloride Use and application,trans-4-propyl-1-phenylcyclohexane technical grade,usp/ep/jp grade.

Related News: Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. (trans-4-Propylcyclohexyl)benzene manufacturer Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. (trans-4-Propylcyclohexyl)benzene supplier Separately, Europe’s drug regulator said on Friday that batches of J&J COVID-19 vaccine made for the region around the time the contamination issues were revealed at the Baltimore plant would, as a precaution, not be used. (trans-4-Propylcyclohexyl)benzene vendor Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. (trans-4-Propylcyclohexyl)benzene factory Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost.